Orthopedic Surgery · New York, NY
NPI
1144245747
Since 2006
Specialty
Orthopedic Surgery
Code 207X00000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
535 E 70th St
New York, NY, 10021
Phone (212) 606-1172
Groups this clinician bills Medicare through
Medicare paid, 2024
$192K
2,173 services
Medicare patients, 2024
1,252
Average age 77
Drug cost, 2024
$2.2M
1,173 prescriptions
Company payments, 2025
$458
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Joseph M Lane was code 99213 (office e&m - established), 1,229 times for 934 patients. In total Joseph M Lane billed 2,173 services in 34 codes, and Medicare paid $192K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-04-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 1,229 | 934 | $74.06 | $91K |
| 99203 Office E&M - New | Office | 196 | 196 | $93.11 | $18K |
| 99214 Office E&M - Established | Office | 184 | 174 | $96.63 | $18K |
| 99204 Office E&M - New | Office | 58 | 58 | $137.90 | $7,998 |
By year: 2022 $138K for 1,581 services; 2023 $158K for 1,600 services; 2024 $192K for 2,173 services.
Medicare prescription drug claims, 2024
In 2024, the drug Joseph M Lane prescribed most often to Medicare patients was Tymlos (Abaloparatide), with 513 prescriptions and refills. In total Joseph M Lane wrote 1,173 Medicare prescriptions that cost $2.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tymlos Abaloparatide | 513 | 514 | 93 | $1.4M |
| Teriparatide Generic | 141 | 143 | 23 | $381K |
| Alendronate Sodium Generic | 111 | 224 | 55 | $777 |
| Calcitriol Generic | 94 | 188 | 36 | $2,516 |
| Forteo Teriparatide | 79 | 79 | 14 | $334K |
| Meloxicam Generic | 33 | 34 | 12 | $199 |
| Calcitonin-Salmon Calcitonin,salmon,synthetic | 27 | 27 | 17 | $1,429 |
| Ultra-Fine Mini Pen Needle Pen Needle, Diabetic | 27 | 75 | 20 | $1,336 |
| Diclofenac Sodium Generic | 23 | 25 | 12 | $704 |
| Evenity (2 Syringes) Romosozumab-Aqqg | 22 | 23 | Under 11 | $57K |
| Prolia Denosumab | 18 | 99 | 13 | $29K |
| Ultra-Fine Short Pen Needle Pen Needle, Diabetic | 14 | 35 | Under 11 | $790 |
| Hydrochlorothiazide Generic | 13 | 33 | Under 11 | $181 |
| Unifine Pentips Pen Needle, Diabetic | 11 | 11 | Under 11 | $0 |
Brand drugs: 718 claims; generic drugs: 389 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Joseph M Lane $458 ($458 in general payments such as food, travel and fees) from 2 companies. The largest payer was Amgen Inc. with $249.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 6 | $249 |
| Radius Health, Inc. | 8 | $208 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.